BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 16135473)

  • 1. Population-based assessment of surgical treatment trends for patients with melanoma in the era of sentinel lymph node biopsy.
    Cormier JN; Xing Y; Ding M; Lee JE; Mansfield PF; Gershenwald JE; Ross MI; Du XL
    J Clin Oncol; 2005 Sep; 23(25):6054-62. PubMed ID: 16135473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health care system and socioeconomic factors associated with variance in use of sentinel lymph node biopsy for melanoma in the United States.
    Bilimoria KY; Balch CM; Wayne JD; Chang DC; Palis BE; Dy SM; Lange JR
    J Clin Oncol; 2009 Apr; 27(11):1857-63. PubMed ID: 19273706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. American Joint Committee on Cancer clinical stage as a selection criterion for sentinel lymph node biopsy in thin melanoma.
    Vaquerano J; Kraybill WG; Driscoll DL; Cheney R; Kane JM
    Ann Surg Oncol; 2006 Feb; 13(2):198-204. PubMed ID: 16418885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond the clinical trials: how often is sentinel lymph node dissection performed for breast cancer?
    Maggard MA; Lane KE; O'Connell JB; Nanyakkara DD; Ko CY
    Ann Surg Oncol; 2005 Jan; 12(1):41-7. PubMed ID: 15827777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete lymph node dissection for sentinel node-positive melanoma: assessment of practice patterns in the United States.
    Bilimoria KY; Balch CM; Bentrem DJ; Talamonti MS; Ko CY; Lange JR; Winchester DP; Wayne JD
    Ann Surg Oncol; 2008 Jun; 15(6):1566-76. PubMed ID: 18414952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A targeted approach to sentinel lymph node biopsies in the parotid region for head and neck melanomas.
    Samra S; Sawh-Martinez R; Tom L; Colebunders B; Salameh B; Truini C; Ariyan S; Narayan D
    Ann Plast Surg; 2012 Oct; 69(4):415-7. PubMed ID: 22964672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inguinal node dissection for melanoma in the era of sentinel lymph node biopsy.
    Sabel MS; Griffith KA; Arora A; Shargorodsky J; Blazer DG; Rees R; Wong SL; Cimmino VM; Chang AE
    Surgery; 2007 Jun; 141(6):728-35. PubMed ID: 17560249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compliance with guidelines in the surgical management of cutaneous melanoma across the USA.
    Wasif N; Gray RJ; Bagaria SP; Pockaj BA
    Melanoma Res; 2013 Aug; 23(4):276-82. PubMed ID: 23695440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma.
    Gannon CJ; Rousseau DL; Ross MI; Johnson MM; Lee JE; Mansfield PF; Cormier JN; Prieto VG; Gershenwald JE
    Cancer; 2006 Dec; 107(11):2647-52. PubMed ID: 17063497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma.
    Paek SC; Griffith KA; Johnson TM; Sondak VK; Wong SL; Chang AE; Cimmino VM; Lowe L; Bradford CR; Rees RS; Sabel MS
    Cancer; 2007 Jan; 109(1):100-8. PubMed ID: 17146784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variations in management of stage I to stage III cutaneous melanoma: a population-based study of clinical practices in France.
    Grange F; Vitry F; Granel-Brocard F; Lipsker D; Aubin F; Hédelin G; Dalac S; Truchetet F; Michel C; Batard ML; Baury B; Halna JM; Schmutz JL; Delvincourt C; Reuter G; Dalle S; Bernard P; Danzon A
    Arch Dermatol; 2008 May; 144(5):629-36. PubMed ID: 18490589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection.
    Debarbieux S; Duru G; Dalle S; Béatrix O; Balme B; Thomas L
    Br J Dermatol; 2007 Jul; 157(1):58-67. PubMed ID: 17501957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Feasibility and technical problems of sentinel node analysis in melanoma].
    Mebazaa A; Kerob D; Toubert ME; Verola O; Servant JM; Baccard M; Billotey C; Bustamante K; Vandici FO; Basset-Seguin N; Ollivaud L; Morel P; Lebbé C
    Ann Chir Plast Esthet; 2007 Feb; 52(1):14-23. PubMed ID: 17141391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
    Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
    Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database.
    Mandalà M; Imberti GL; Piazzalunga D; Belfiglio M; Labianca R; Barberis M; Marchesi L; Poletti P; Bonomi L; Novellino L; Di Biagio K; Milesi A; Guerra U; Tondini C
    Eur J Cancer; 2009 Sep; 45(14):2537-45. PubMed ID: 19553103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sentinel node staging of primary melanoma by the "10% rule": pathology and clinical outcomes.
    Emery RE; Stevens JS; Nance RW; Corless CL; Vetto JT
    Am J Surg; 2007 May; 193(5):618-22; discussion 622. PubMed ID: 17434368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of first-recurrence and post-recurrence survival in patients with primary cutaneous melanoma after sentinel lymph node biopsy.
    Dalal KM; Patel A; Brady MS; Jaques DP; Coit DG
    Ann Surg Oncol; 2007 Jun; 14(6):1934-42. PubMed ID: 17406951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of sentinel lymph node involvement in a modern, large series of desmoplastic melanoma.
    Egger ME; Huber KM; Dunki-Jacobs EM; Quillo AR; Scoggins CR; Martin RC; Stromberg AJ; McMasters KM; Callender GG
    J Am Coll Surg; 2013 Jul; 217(1):37-44; discussion 44-5. PubMed ID: 23791271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors predictive of nonsentinel lymph node involvement and clinical outcome in melanoma patients with metastatic sentinel lymph node.
    Rossi CR; De Salvo GL; Bonandini E; Mocellin S; Foletto M; Pasquali S; Pilati P; Lise M; Nitti D; Rizzo E; Montesco MC
    Ann Surg Oncol; 2008 Apr; 15(4):1202-10. PubMed ID: 18165880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histological features of melanoma sentinel lymph node metastases associated with status of the completion lymphadenectomy and rate of subsequent relapse.
    Govindarajan A; Ghazarian DM; McCready DR; Leong WL
    Ann Surg Oncol; 2007 Feb; 14(2):906-12. PubMed ID: 17136471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.